Home > Insider Trading > Filing (0001209191-17-065954)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1598646	Minerva Neurosciences Inc.	NERV	Pharmaceutical Preparations (2834)	260784194

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1610382	Geoff Race	C/O Minerva Neurosciences, Inc. 1601 Trapelo Road, Suite 286 Waltham MA 02451	Evp, Cfo & Cbo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-12-14	12,500	$0.00	197,698	No	4	M	Direct
Common Stock	Disposition	2017-12-14	5,829	$5.79	191,869	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2017-12-13	200,000	$0.00	200,000	$6.10
Common Stock	Restricted Stock Unit	Disposition	2017-12-14	12,500	$0.00	12,500	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
200,000		2027-12-13	No	4	A	Direct
37,500			No	4	M	Direct

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock
Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stockin connection with the settlement of the vested portion of RSUs pursuant to the terms of that certain RSU Agreement between the Reporting Person and the Issuer, as reflected in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.75 to $5.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
This option vests as to 25% of the shares on December 13, 2018 and then in quarterly installments over 3 years thereafter.
Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date.